BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

879 related articles for article (PubMed ID: 11551252)

  • 1. Effect of seasonal allergen exposure on mucosal IL-16 and CD4+ cells in patients with allergic rhinitis.
    Pullerits T; Lindén A; Malmhäll C; Lötvall J
    Allergy; 2001 Sep; 56(9):871-7. PubMed ID: 11551252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of pollen and nasal glucocorticoid on FOXP3+, GATA-3+ and T-bet+ cells in allergic rhinitis.
    Malmhäll C; Bossios A; Pullerits T; Lötvall J
    Allergy; 2007 Sep; 62(9):1007-13. PubMed ID: 17686103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of anti-immunoglobulin E on nasal inflammation in patients with seasonal allergic rhinoconjunctivitis.
    Bez C; Schubert R; Kopp M; Ersfeld Y; Rosewich M; Kuehr J; Kamin W; Berg AV; Wahu U; Zielen S
    Clin Exp Allergy; 2004 Jul; 34(7):1079-85. PubMed ID: 15248853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluticasone propionate aqueous nasal spray reduces inflammatory cells in unchallenged allergic nasal mucosa: effects of single allergen challenge.
    Holm A; Dijkstra M; Kleinjan A; Severijnen LA; Boks S; Mulder P; Fokkens W
    J Allergy Clin Immunol; 2001 Apr; 107(4):627-33. PubMed ID: 11295650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of topical glucocorticoid treatment of hay fever: IL-5 and eosinophil activation during natural allergen exposure are suppressed, but IL-4, IL-6, and IgE antibody production are unaffected.
    Kita H; Jorgensen RK; Reed CE; Dunnette SL; Swanson MC; Bartemes KR; Squillace D; Blomgren J; Bachman K; Gleich GJ
    J Allergy Clin Immunol; 2000 Sep; 106(3):521-9. PubMed ID: 10984373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased number of CD34+ cells in nasal mucosa of allergic rhinitis patients: inhibition by a local corticosteroid.
    Sergejeva S; Malmhäll C; Lötvall J; Pullerits T
    Clin Exp Allergy; 2005 Jan; 35(1):34-8. PubMed ID: 15649263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical glucocorticosteroid (fluticasone propionate) inhibits cells expressing cytokine mRNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis.
    Masuyama K; Jacobson MR; Rak S; Meng Q; Sudderick RM; Kay AB; Lowhagen O; Hamid Q; Durham SR
    Immunology; 1994 Jun; 82(2):192-9. PubMed ID: 7927488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-13 mRNA and immunoreactivity in allergen-induced rhinitis: comparison with IL-4 expression and modulation by topical glucocorticoid therapy.
    Ghaffar O; Laberge S; Jacobson MR; Lowhagen O; Rak S; Durham SR; Hamid Q
    Am J Respir Cell Mol Biol; 1997 Jul; 17(1):17-24. PubMed ID: 9224205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-9 and c-Kit+ mast cells in allergic rhinitis during seasonal allergen exposure: effect of immunotherapy.
    Nouri-Aria KT; Pilette C; Jacobson MR; Watanabe H; Durham SR
    J Allergy Clin Immunol; 2005 Jul; 116(1):73-9. PubMed ID: 15990777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seasonal idiopathic rhinitis with local inflammatory response and specific IgE in absence of systemic response.
    Rondón C; Doña I; López S; Campo P; Romero JJ; Torres MJ; Mayorga C; Blanca M
    Allergy; 2008 Oct; 63(10):1352-8. PubMed ID: 18782115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of nasal mucosal eotaxin in patients with allergic rhinitis during grass pollen season: effect of a local glucocorticoid.
    Pullerits T; Lindén A; Praks L; Cardell LO; Lötvall J
    Clin Exp Allergy; 2000 Oct; 30(10):1469-75. PubMed ID: 10998025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Grass pollen immunotherapy: symptomatic improvement correlates with reductions in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season.
    Wilson DR; Nouri-Aria KT; Walker SM; Pajno GB; O'Brien F; Jacobson MR; Mackay IS; Durham SR
    J Allergy Clin Immunol; 2001 Jun; 107(6):971-6. PubMed ID: 11398073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal fluticasone propionate inhibits recovery of chemokines and other cytokines in nasal secretions in allergen-induced rhinitis.
    Weido AJ; Reece LM; Alam R; Cook CK; Sim TC
    Ann Allergy Asthma Immunol; 1996 Nov; 77(5):407-15. PubMed ID: 8933780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bet v 1-specific IgA increases during the pollen season but not after a single allergen challenge in children with birch pollen-induced intermittent allergic rhinitis.
    Keen C; Johansson S; Reinholdt J; Benson M; Wennergren G
    Pediatr Allergy Immunol; 2005 May; 16(3):209-16. PubMed ID: 15853949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of nasal immunohistology in patients with seasonal rhinoconjunctivitis treated with topical steroids or specific allergen immunotherapy.
    Rak S; Heinrich C; Scheynius A
    Allergy; 2005 May; 60(5):643-9. PubMed ID: 15813810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine expression in the lower airways of nonasthmatic subjects with allergic rhinitis: influence of natural allergen exposure.
    Chakir J; Laviolette M; Turcotte H; Boutet M; Boulet LP
    J Allergy Clin Immunol; 2000 Nov; 106(5):904-10. PubMed ID: 11080713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response.
    Tulic MK; Fiset PO; Christodoulopoulos P; Vaillancourt P; Desrosiers M; Lavigne F; Eiden J; Hamid Q
    J Allergy Clin Immunol; 2004 Feb; 113(2):235-41. PubMed ID: 14767435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-8 secretion in patients with allergic rhinitis after an allergen challenge: interleukin-8 is not the main chemotactic factor present in nasal lavages.
    Gosset P; Tillie-Leblond I; Malaquin F; Durieu J; Wallaert B; Tonnel AB
    Clin Exp Allergy; 1997 Apr; 27(4):379-88. PubMed ID: 9146930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allergen-induced changes of B-cell phenotypes in patients with allergic rhinitis.
    Davidsson A; Karlsson MG; Hellquist HB
    Rhinology; 1994 Dec; 32(4):184-90. PubMed ID: 7535471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
    Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
    Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.